Actively Recruiting
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
Led by University of Colorado, Denver · Updated on 2026-04-08
22000
Participants Needed
2
Research Sites
143 weeks
Total Duration
On this page
Sponsors
U
University of Colorado, Denver
Lead Sponsor
A
Agency for Healthcare Research and Quality (AHRQ)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study plans to learn more about whether a stakeholder-informed, standardized inpatient vaccination program will increase influenza vaccination rates of hospitalized children across US pediatric health systems. The first part of the study is to form a multidisciplinary team of stakeholders, including parents, providers, nurses, pharmacists, informaticists, data analysts and communication experts across three sites in synthesizing a best practice implementation guide for an inpatient influenza vaccination program, which will then be piloted at these three sites.
CONDITIONS
Official Title
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 6 months of age
- Admitted to an inpatient unit at a participating health system
You will not qualify if you...
- Admission to critical care sites or hematology-oncology services
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Ann and Robert Lurie's Children Hospital of Chicago
Chicago, Illinois, United States, 60611
Actively Recruiting
2
Seattle Children's Hospital
Seattle, Washington, United States, 98105
Actively Recruiting
Research Team
S
Suchitra Rao
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here